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Abstract
Background: The aim of the study was to identify the changes in Health Related Quality of Life
(HRQL) 3 months after discharge from hospital, in patients who have had an acute coronary
episode, and to determine the clinical and sociodemographic variables that explain those changes.
Methods: HRQL was assessed in 132 patients while they were admitted to the hospital and at 3
months after discharge, using the SF-36 health questionnaire. To identify the variables associated
with the change, multiple linear regression models were constructed for two summary dimensions
of the SF-36 (PCS and MCS) taking the change in the score of the dimension as dependent variable.
Results:  There were no significant differences between the patients who completed the
monitoring (n = 76) and those who were dropped out. After three months, a significant decrease
was observed in the dimensions of physical functioning, general health, vitality, and Physical
Summary Component (PCS). The variables revascularisation, age, and the interaction between
previous history of coronary heart disease (CHD) and the presence of one or more risk factors
explained 16.6% of the decrease in the PCS. The decrease in the PCS was 6.4 points less in the
patients who had undergone revascularisation, 0.2 points less for each year of age, and 4.7 points
less in the patients who had antecedents of the illness as well as one or more risk factors.
Conclusion: The dimensions most affected at three months after an acute coronary episode were
those related to the physical component. Undergoing revascularisation improved the PCS in
patients, but in the younger patients and those without personal antecedents or risk factors, the
PCS was affected more, perhaps due to greater expectations for recovery in these patients.
Background
Although the traditional measures of mortality and mor-
bidity are frequently used as primary end points in coro-
nary heart disease (CHD), they have limitations because
they require prolonged periods of observations and are
expensive to measure.
Despite the obvious value of these measures, others like
health related quality life (HRQL) are considered of great
importance. [1]. HRQL seems to be useful for defining
health both in terms of how individuals feel (distress and
well-being) and in terms of how they evaluate their health
and prospects for the future [2]. Several general and dis-
ease-specific instruments have been developed to assess
different dimensions of HRQL in coronary patients [3,4],
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with physical and mental health as their principal compo-
nent [5].
Measuring changes in population HRQL is important for
assessing interventions and predicting needs for social
care. The focus of attention in the immediate period fol-
lowing a cardiac attack is generally the physical function-
ing, but following discharge from hospital and in the
longer term, general health, vitality, social and emotional
functions could be at least as important. [6].
Where studies are available, the impact on HRQL in the
short and medium term after the cardiac attack appears
variable, and the results are limited to populations of
patients receiving specific treatment interventions. [7].
Brown et al [6] found lower scores on HRQL 4 years after
myocardial infarction, compared with the community
normative score, and Brink et al [8] found similar results
both for the physical and the mental component 5
months after an acute myocardial infarction (AMI). On
the other hand, Beck et al [7] found that, although mean
scores are slightly lower at 6 months than at baseline, they
did not change over the course of follow-up.
The effect of the sociodemographic variables on the
HRQL in coronary patients has been described by several
authors who have observed a lower HRQL in women and
in subjects of low social class [9,10]. Similarly differences
in HRQL have been observed in function of the presence
of cardiovascular risk factors or of clinical manifestations
of the disease [11,12].
Furthermore, coronary heart disease has frequently been
associated with moderate to severe mental disorders, and
anxiety and depression has been related with worse HRQL
in these patients [13].
Despite all the preceding considerations, little is known in
follow-up studies about the effect that the sociodemo-
graphic, clinical and psychological variables have on the
HRQL after a coronary attack. We therefore carried out
this study in order to identify the changes in HRQL at 3
months after discharge from hospital, and to identify the
key clinical, demographic and psychological characteris-
tics of patients associated with these changes.
We set up the hypothesis that physical functioning is the
dimension of the HRQL showing the largest decrease after
3 months of follow-up and that age, and the clinical and
mental health variables are those most closely related to
these changes.
Methods
A follow-up study was carried out in the cardiology unit of
a University Hospital in the south of Spain (850 beds),
where 185 consecutive patients admitted for a suspected
acute episode of coronary heart disease were identified.
132 of the patients were diagnosed with acute myocardial
infarction (AMI) or unstable angina on the basis of clini-
cal, biochemical and electrocardiographic criteria
described elsewhere [14] and were included in the study.
Patients with non-ischemic or non-cardiological precor-
dial pain were excluded.
The number of patients studied was based on the sample
size calculated to detect a minimum difference of 5 points
(α = 0.05; 1-β = 0.80) in the mean HRQL scores between
the two groups of patients with AMI and unstable angina
[15,16].
Baseline information (obtained 3–7 days after admission,
when the patient was clinically stable) and 3 months after
discharge, was obtained by a single previously-trained
interviewer, who was not the cardiologist who made the
clinical evaluation. Before inclusion, all the patients were
asked for their informed consent and all agreed to partic-
ipate (n = 132).
The ethical basis of the study was approved by the
Research Committee of the Hospital.
Sociodemographic and clinical information was obtained
from a structured questionnaire and from the patients'
clinical records, and the Spanish Society of Epidemiology
(SSE) classification [17] was used to determine social
class. Cardiovascular risk factors (use of tobacco, hyper-
tension, obesity and diabetes) and clinical information of
the patients (previous history of CHD, revascularisation,
ejection fraction, number of vessels obstructed, re-hospi-
talisation during follow-up, co-morbidity, and diagnostic
group) were considered to be present when they were
explicitly stated in the clinical records or in the patient's
discharge report; and the existence of comorbidity other
than cardiovascular risk factors was considered if another
chronic pathologies (of digestive, respiratory, osteomus-
cular, neurological or other character) also figured in the
patients' clinical records.
Health-related quality of life was assessed using the eight
specific and the two Physical and Mental Components
Summaries (PCS and MCS) of the SF-36 health question-
naire. For each of the dimensions of the questionnaire
(PF: physical functioning; RP: physical role; BP: body
pain; GH: general health; VT: vitality; SF: social function-
ing; RE: emotional role; MH: mental health), the items
were coded, aggregated and transformed into a scale from
0 (the worst state of health for that dimension) to 100BMC Public Health 2006, 6:18 http://www.biomedcentral.com/1471-2458/6/18
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(the best state of health). The summary indices (PCS and
MCS) were calculated by standardizing each of the dimen-
sions using the means and standard deviations of the
Spanish population for their subsequent aggregation and
transformation [18].
Mental health was measured using the GHQ-28 (General
Health Questionnaire), an instrument developed as a
method of screening to detect psychiatric non-psychotic
disorders. The 28-item version was translated into Span-
ish and validated by Lobo et al [19] and it has already
been validated as a means of detecting problems in cardi-
ology patients [20]. This questionnaire consists of 28
items grouped into four sub-scales of 7 items each, pro-
viding additional information on: somatic symptoms of
psychological origin (scale A); Anxiety or distress (scale
B); Social dysfunction in every-day activities (scale C);
Depression (scale D).
Table 1: Comparison of the characteristics of the patients at the start and after 3 months of follow-up.
Sociodemographic variables
ONSET n(%) 3 MONTHS n (%) p
Age 0.26
<46 3 (5.4) 9(11.8)
46–55 9(16.1) 18(23.7)
56–65 21(37.5) 23(30.3)
>65 23(41.0) 26(34.2)
Sex 0.34
Men 41(73.2) 62(81.6)
Women 15(26.8) 14(18.4)
Social class 0.67
Housewives 12(22.2) 12(15.8)
I and II 5(9.3) 5(6.6)
III 8(14.8) 16(21.0)
IV and V 29(53.7) 43(56.6)
Clinical variables
ONSET n (%) 3 MONTHS n (%) P
Diagnostic group 0.91
Acute myocardial infarction 26(46.4) 37(48.7)
Unstable angina 30(53.6) 39(51.3)
GHQ-28 (initial) 0.84
< 6 29(51.8) 39(51.3)
≥ 6 27(48.2) 37(48.7)
Tobacco 0.82
Smoker 25(45.5) 33(43.4)
Non smoker 30(54.5) 43(56.6)
Diabetes 0.53
Yes 34(61.8) 51(68.0)
No 21(38.2) 24(31.6)
Hypercholesterolemia 0.46
Yes 36(65.5) 45(59.2)
No 19(34.5) 31(40.8)
High blood pressure 0.22
Yes 23(41.8) 40(52.6)
No 32(58.2) 36(47.4)
Obesity 0.34
Yes 19(35.8) 19(25.7)
No 34(64.2) 55(72.3)
Previous history of CHD. 0.20
Yes 26(46.4) 27(35.5)
No 30(53.6) 49(64.5)
Comorbidity 0.63
Yes 22(39.3) 34(44.8)
No 34(60.7) 42(55.2)BMC Public Health 2006, 6:18 http://www.biomedcentral.com/1471-2458/6/18
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The score in the scale runs from 0 to 28 points, in which a
higher score indicates a higher probability of mental dis-
orders. The cut-off point recommended for the question-
naire is ≥6 points, thus providing a sensitivity of 76.9%
and a specificity of 90.2% [19].
Statistical analysis
To compare the sociodemographic and clinical character-
istic of the patients at onset and 3 months alter discharge,
the chi-squared and Pearson tests were done.
An analysis of the raw scores using the t-test for repeated
measurements and a stratification analysis by the clinical
and sociodemographic variables studied were performed
for this study of the changes observed in the different
dimensions of the SF-36 during the follow-up. A result
was considered statistically significant if the p value was <
0.05
Multiple linear regression models were used to identify
factors influencing the variance of the HRQL score 3
months after discharge, for the PCS and MCS of the SF-36.
The change in HRQL scores was used as dependent varia-
ble (baseline score – 3 months score) and the independ-
ent variables to be included in the two models (age, sex,
social class, GHQ-28 score, previous history of CHD,
comorbidity, risk factors, revascularisation, re-hospitalisa-
tion and number of vessels obstructed) were selected fol-
lowing a stepwise method.
A negative result in the dependent variable reflects an
improvement in HRQL during follow-up, and a negative
β coefficient in the model indicates a decrease in the dif-
ference of the scores obtained after 3 months of follow-
up, with respect to the initial scores.
The analysis was performed using the SPSS.v10 program.
Results
The results presented in this paper correspond to those
obtained at the start and after 3 months of follow-up, of a
group of patients who have suffered an acute coronary
episode, and forms part of a wider study with a follow-up
period of 6 months.
Of the 132 patients who were initially included in the
study, 76 (57.6%) remained after three months of follow-
up. Of these 76 patients, the majority were males
(81.6%), belonging to classes IV and V of the SSE classifi-
cation (56.6%), and the most frequent vascular risk fac-
tors were the use of tobacco and the presence of high
blood pressure. The presence of co morbidity was detected
in 44.8% of the patients, and less than half of them pre-
sented a previous history of coronary heart disease. Also
significant was the high percentage of patients with GHQ-
28 scores of ≥6 (48.7%).
Table 1 show that there were no significant differences in
socio-demographic and clinical characteristics of the
responding and non-responding patients during the fol-
low-up.
The analysis of the differences between each of the eight
specific and the two summary dimensions of the SF-36 at
baseline and 3 months after discharge shows a significant
decrease in the scores obtained in the dimensions physical
functioning, general health, vitality and in the summary
physical component (Table 2). No differences were
observed in the rest of the dimensions of the SF-36 (Table
2).
In the stratification analysis, a significant decrease was
observed after 3 months of follow-up in the dimensions
of physical functioning, general health and PCS in most of
the variables studied (Tables 3 and 4). No changes were
Table 2: Changes in HRQL 3 months after discharge from the hospital
ONSET 3 MONTHS p
Mean SD Mean SD
PF 77.3 25.77 61.4 26.69 0.000
RP 67.4 42.23 57.9 47.99 0.18
BP 65.9 30.91 69.3 30.00 0.39
GH 55.1 19.69 50.5 17.97 0.03
VT 66.7 23.58 60.5 22.36 0.04
SF 80.6 25.69 80.1 25.09 0.86
RE 62.7 46.18 60.1 48.69 0.67
MH 66.6 24.58 64.2 24.31 0.33
PCS 47.1 9.97 42.8 9.95 0.006
MCS 44.1 15.16 45.2 13.95 0.78
PF: physical functioning; RP: physical role; BP: body pain; GH: general health.
PCS: physical component summary; VT: vitality; SF: social functioning; RE: emotional role; MH: mental health; MCS: mental component summary; 
SD: standard deviation.B
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Table 3: PCS and physical dimensions scores of SF-36 health questionnaire at baseline and 3 months after discharge from the hospital (demographic and clinical variables)
PF RP BP GH PCS
ONSET 3 MONTHS P ONSET 3 MONTHS P ONSET 3 MONTHS P ONSET 3 MONTHS P ONSET 3 MONTHS P
Diagnostic group
AMI 85.2(22.8) 66.6(26.6) 0.000 71.6(40.9) 61.5(48.1) 0.333 69.6(31.7) 77.6(26.6) 0.184 63.6(17.4) 56.3(18.6) 0.024 50.2(9.3) 45.2(10.4) 0.040
Unstable angina 69.7(26.4) 56.5(26.2) 0.001 63.5(43.6) 54.5(48.3) 0.371 62.4(30.1) 61.4(31.2) 0.855 47.2(18.5) 44.9(15.7) 0.459 44.3(9.8) 40.6(9.1) 0.080
Risk factors
None 91.2(9.7) 66.2(29.2) 0.001 83.8(34.2) 47.0(49.1) 0.007 70.5(26.9) 68.0(32.7) 0.765 62.3(21.9) 53.3(15.6) 0.093 51.6(11.0) 41.3(13.2) 0.011
One or more 73.3(27.5) 60.1(26.0) 0.000 62.7(43.4) 61.0(47.6) 0.838 64.6(32.1) 69.7(29.5) 0.265 52.9(18.6) 49.6(18.6) 0.169 45.7(9.3) 43.2(8.8) 0.159
Previous history CHD
No 86.5(19.9) 67.9(26.4) 0.000 75.0(38.8) 59.7(48.1) 0.086 70.3(28.7) 73.1(27.5) 0.542 58.0(19.9) 51.9(17.5) 0.010 50.6(8.9) 44.4(10.1) 0.002
Yes 60.5(27.0) 49.6(23.2) 0.042 53.7(45.3) 54.6(48.5) 0.940 57.9(33.6) 62.3(33.5) 0.564 49.8(18.5) 47.9(18.9) 0.658 40.7(8.5) 39.9(9.2) 0.836
Sex
Men 80.5(24.0) 64.7(25.5) 0.000 68.5(41.7) 56.4(25.5) 0.137 63.9(31.0) 71.2(29.3) 0.123 56.1(19.5) 49.8(16.9) 0.005 47.1(10.2) 42.9(9.9) 0.014
Women 62.8(29.1) 47.1(28.2) 0.032 62.5(45.7) 64.3(49.7) 0.908 74.7(29.8) 61.0(32.8) 0.007 50.6(20.4) 53.3(22.3) 0.683 46.8(9.1) 42.3(10.3) 0.263
Age
<56 82.8(24.9) 68.3(23.0) 0.000 69.4(40.6) 38.9(48.2) 0.023 60.1(32.6) 66.6(30.6) 0.342 52.7(20.2) 49.5(17.3) 0.225 48.3(10.6) 42.4(9.7) 0.006
56–65 83.4(19.1) 63.7(28.4) 0.002 64.1(45.1) 65.2(48.7) 0.927 72.7(28.4) 64.7(36.8) 0.276 53.4(20.8) 50.4(21.9) 0.559 47.4(9.1) 44.2(11.3) 0.302
> 65 66.1(28.7) 52.3(27.0) 0.013 68.3(42.7) 71.1(42.2) 0.806 66.0(31.1) 76.2(21.4) 0.135 58.8(18.3) 51.7(15.5) 0.041 44.5(9.8) 42.3(8.9) 0.324
Social class
I, II, III 77.8(24.1) 66.9(23.0) 0.016 61.9(43.0) 64.2(45.8) 0.871 69.2(28.3) 71.0(27.7) 0.819 56.8(21.2) 52.4(14.7) 0.208 47.2(10.2) 44.9(8.7) 0.295
IV, V, housewives 77.1(26.5) 59.3(27.8) 0.000 69.5(42.1) 55.4(48.9) 0.087 64.6(31.9) 68.6(31.0) 0.397 54.4(19.2) 49.7(19.1) 0.084 46.5(9.8) 42.1(10.2) 0.014B
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Table 4: PCS and physical dimensions scores of SF-36 health questionnaire. Baseline and 3 months after discharge from the hospital. (Clinical variables)
PF RP BP GH PCS
ONSET 3 MONTHS p ONSET 3 MONTHS p ONSET 3 MONTHS p ONSET 3 MONTHS p ONSET 3 MONTHS p
Revascularisation
No 75.2(26.9) 59.7(27.6) 0.000 68.2(42.3) 60.1(47.3) 0.338 70.1(31.3) 67.7(29.4) 0.601 55.1(21.4) 49.0(17.9) 0.022 47.2(9.9) 42.7(8.6) 0.004
Yes 81.7(19.7) 69.6(17.8) 0.134 76.8(38.5) 48.2(50.4) 0.063 50.6(25.1) 75.2(30.9) 0.015 46.7(14.9) 51.2(17.8) 0.286 43.8(7.9) 44.4(10.6) 0.842
Ejection fraction
< 50 77.8(28.8) 61.4(32.1) 0.099 50.0(50.0) 75.0(43.3) 0.251 73.1(35.4) 77.0(28.6) 0.714 60.7(25.0) 49.4(19.2) 0.211 44.8(15.3) 42.9(8.8) 0.639
≥ 50 78.6(26.1) 63.6(25.4) 0.000 72.2(39.4) 58.1(48.2) 0.191 66.4(28.0) 68.0(31.6) 0.787 51.4(19.6) 51.6(19.3) 0.932 46.3(8.3) 43.7(8.5) 0.162
Number of vessels
One vessel 79.7(26.6) 68.4(25.5) 0.028 80.6(36.1) 46.5(48.3) 0.009 71.9(29.3) 77.3(27.4) 0.443 57.3(21.2) 50.5(17.9) 0.017 48.3(8.5) 43.6(8.2)0 . 0 3 5
More than one vessel 77.8(25.6) 63.7(25.9) 0.002 55.3(45.3) 69.6(45.8) 0.232 59.7(30.8) 67.2(31.4) 0.262 51.1(16.4) 52.3(19.3) 0.730 43.6(10.3) 43.6(9.9) 0.996
Re-admissions
None 77.9(25.7) 64.8(27.5) 0.000 72.6(39.6) 55.2(48.3) 0.060 65.8(30.9) 70.2(31.1) 0.392 54.8(19.6) 49.3(17.8) 0.022 48.1(9.2) 43.4(9.3) 0.003
Some 77.7(25.2) 58.7(26.2) 0.001 62.1(46.5) 62.9(47.5) 0.942 68.6(31.8) 68.9(28.4) 0.968 53.4(20.5) 51.3(18.6) 0.621 45.2(11.2) 42.4(11.0) 0.329
Comorbidity
No 83.2(22.6) 66.5(24.6) 0.000 66.6(41.5) 56.5(49.1) 0.283 64.8(31.0) 68.5(30.8) 0.480 56.7(20.1) 54.3(16.3) 0.383 46.9(9.3) 44.3(9.4) 0.094
Yes 70.0(27.7) 55.1(28.1) 0.002 68.3(43.6) 59.5(47.2) 0.433 67.2(31.1) 70.2(29.3) 0.632 52.9(19.2) 45.6(18.9) 0.038 46.4(10.7) 41.0(10.2) 0.037
GHQ-28
< 6 89.6(16.3) 71.8(26.5) 0.000 80.1(36.8) 70.5(45.5) 0.312 73.3(31.5) 76.7(27.1) 0.501 65.5(15.4) 57.9(15.9) 0.011 47.7(10.2) 47.1(8.5) 0.754
≥ 6 64.3(27.7) 50.5(22.4) 0.006 54.0(43.9) 44.6(47.5) 0.389 58.2(28.7) 61.5(31.2) 0.596 43.8(17.6) 42.6(16.7) 0.686 45.8(10.3) 38.4(9.1) 0.002BMC Public Health 2006, 6:18 http://www.biomedcentral.com/1471-2458/6/18
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observed in the MCS nor in any of the dimensions com-
prising it, except for vitality where a decrease was observed
of the score in the patients with AMI, without antecedents
of CHD, without cardiovascular risk factors, males, those
with lower scores in the GHQ-28, those belonging to the
lowest social classes, of younger ages, those with revascu-
larisation and with ejection fraction lower than 50 (Fig 1
and Fig 2).
In the dimension bodily pain it is notable that the scores
at 3 months of follow-up increased in the patients with
revascularisation, and the scores decreased in the women.
(Table 3 and 4)
Only the multiple regression model constructed with the
PCS as the dependent variable is considered relevant for
this analysis of the variables associated with the changes
occurring during the follow-up. This model shows revas-
cularisation performed during the follow-up, age and the
interaction between personal history of CHD and the
presence of one or more risk factors to be explanatory var-
iables of the change in the PCS. Thus, the decrease in the
PCS at 3 months was 6.4 points less in those patients sub-
mitted to a revascularisation, and 0.2 points less for each
year of age. Further, although the presence of one or more
risk factors or of antecedents of CHD does not explain the
changes in the PCS, a reduced decrease (4.7 points) at 3
months is found in those patients who had personal his-
tory of the disease if they also had one or more cardiovas-
cular risk factor (Table 5).
Discussion
This study reveals a decrease in the summary physical
component of the HRQL in coronary patients 3 months
after having an acute episode of the disease, and identifies
the patient characteristics associated with this change. In
the study it is also demonstrated that the scores in the
dimensions of the HRQL related to the mental compo-
nent are maintained during the follow-up. However, these
scores were low at baseline and lower than those observed
in the Spanish general population [21].
These results are in agreement with those obtained by
other authors such as Hemingway et al [17] and Brown et
al [6], who find that the physical functioning is affected
more than mental functioning. However, in patients with
AMI, Beck and cols [7] find only small differences in the
PCS of the SF-36 after 6 months of follow-up, and find no
differences at one year; Bengtson et al [22] find significant
improvement in physical health over time only in patients
older than 59 years of age.
Clinical and demographic variables and vitality dimension  score of the SF-36 health questionnaire at baseline and 3  months after discharge from hospital Figure 1
Clinical and demographic variables and vitality dimension 
score of the SF-36 health questionnaire at baseline and 3 
months after discharge from hospital.  (Cont'd)   Base-
line.   3 Months.
Clinical and demographic variables and vitality dimension  score of the SF-36 health questionnaire at baseline and 3  months after discharge from hospital Figure 2
Clinical and demographic variables and vitality dimension 
score of the SF-36 health questionnaire at baseline and 3 
months after discharge from hospital. (Cont'd)   Baseline. 
 3 Months.BMC Public Health 2006, 6:18 http://www.biomedcentral.com/1471-2458/6/18
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Although in our study vitality decreased after 3 months of
follow-up, its effect remained hidden by the MCS of the
HRQL, which showed no difference from the base score.
These results are in accordance with those found by Veen-
stra et al. [23] and could be explained by the inclusion in
the MCS of other dimensions such as social functioning,
mental health and emotional role that showed no
changes during the follow-up. Heller et al [24] find poor
emotional health in patients with AMI or angina 6 weeks
after discharge, but this dimension returns to baseline lev-
els at 6 months. However Rubenach et al.[25] show that
mental health remained poorer compared to baseline at 6
months after discharge, and attributed these differences to
the effect on the summary score of the dimensions vitality
and social functioning, which were low at 6 months com-
pared to baseline values.
Among the factors associated with the change in the PCS,
age, revascularisation and the interaction between ante-
cedents of coronary heart disease and the existence of cor-
onary risk factors were the most important. In an analysis
of the factors associated with the HRQL at 6 and 12
months after discharge, Beck et al. [7] observed that age
was a factor that predicted an impaired PCS in both cases,
with the older patients obtaining lower scores. These
results are not in accordance with those found in our
study where for each year that the age increases, the PCS
score improves by 0.2 points. One explanation of these
results, which has been shown in other disease states,
could be that the experience of the elderly and the degree
of dissatisfaction felt at a given level of disability is less
than in younger individuals [6,26]. Another possible
explanation could be that younger patients were treated
more aggressively after initial hospitalisation [7,27], mak-
ing the recovery longer and affecting the HRQL more.
However, this latter explanation does not appear plausi-
ble due to the results having been adjusted for the treat-
ment received by the patients, in that study.
Revascularisation was the only clinical variable associated
with change in the PCS, and no association was observed
with other variables related to the severity of the disease or
the administration of treatments. These results are in
accordance with those observed by Veenstra at al [23].
However Beck et al [7] find a decrease in the scores of the
PCS in the patients who have had revascularisation. These
differences may perhaps be due to Beck and cols consider-
ing the previous revascularisation as a characteristic relat-
ing to the clinical history of the patients, as against
ourselves considering revascularisation as a therapeutic
measure undergone during the follow-up.
The antecedents of CHD and the presence of cardiovascu-
lar risk factors considered individually were not variables
associated with the change in the PCS scores. However,
those patients who met the two criteria present a PCS
score at 3 months that is more favourable than their initial
score. According to Steward et al [28], first-time admission
patients with ischemic heart disease assessed their illness
as less threatening and used different strategies for coping
compared with those having multiple admissions for car-
diac disease. It is also been suggested that individuals with
a strong sense of coherence – an internal resource for cop-
ing that helps the person confront stressful situations –
may be better prepared to cope with acute myocardial inf-
arction [29].
Patient's sex and the existence of "probable mental dis-
ease" were not variables associated with the change in the
PCS score during the follow-up, unlike the findings of
other studies [10] although they were variables that pre-
dicted the PCS, and especially the MCS, at baseline [30].
In the present study, the GHQ-28 questionnaire was com-
pleted before discharge and probably this assessment did
not reflect the mental health of the patients 3 months
later.
One of the limitations of the study could be the use of a
generic instrument for the assessment of HRQL that may
be less sensitive to change than a specific instrument.
However, this instrument was used because we were inter-
ested in measuring subjects' perceptions of their "overall
Table 5: Multiple linear regression model for the change in the physical component summary (PCS)
Coefficient of determination of the model: R2 = 0.166. Significance = 0.012
Coefficients Standard error Significance
Constant 21.737 7.430 0.005
Revascularisation -6.497 3.205 0.047
Age -0.259 0.122 0.037
One or more risk factors* × 
antecedents of CHD**
-4.783 2.684 0.080
*One or more risk factors: Use of tobacco, diabetes, hypercholesterolemia, high blood pressure, obesity. **CHD: coronary heart disease.
Reference categories: No revascularisation. Age in years. No risk factor. No antecedents of CHD.BMC Public Health 2006, 6:18 http://www.biomedcentral.com/1471-2458/6/18
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HRQL" after a coronary attack. Furthermore, the small
sample in the study could diminish the statistical power
and underestimate the differences in the follow-up. [31].
Another of the limitations is that it has not been possible
to calculate the minimum clinically important difference,
because no subjective evaluation was made of the change
in the state of health of the patient different from that of
the SF-36. Nevertheless, changes of more than 12% over
the initial score have been considered acceptable for the
SF-36 by other authors [32], and in our results differences
in the PCS of more than this magnitude are observed.
Conclusion
Our findings suggest that in a non-selected cohort of short
term survivors of a coronary attack, there is a notable
effect on HRQL, especially in physical functioning, in
younger patients without personal antecedents or coro-
nary risk factors, that could go unrecognised. In addition,
it demonstrates the need for complementary treatment to
improve the mental component of HRQL in the patients
of the study.
The identification of predictors of HRQL at the time of
admission would allow physicians to identify those
patients with a worse HRQL and to compare the effects of
different treatments during follow-up.
Also, in view of the results obtained, the SF-36 seems to be
a sensitive tool for HRQL assessment in coronary patients,
and provides valuable information not identified in rou-
tine clinical evaluation.
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